Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
Clinical trial NCT00157976 · UNKNOWN
Trial details
- NCT number
- NCT00157976
- Sponsor
- Miravant Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.